Vol. 2 No. 1 (2022): Precision Medicine Communications

View Vol. 2 No. 1 (2022): Precision Medicine Communications

Published: 2022-06-30

Editorial

Precision Medicine & Drug Repurposing for Cardiovascular Diseases; Challenges and Opportunities

Sagheer Ahmed

01
- PDF

In This Issue

Editor's Summaries of the Articles Published in This Issue of Precision Medicine Communications

Editorial Staff

03-04
- PDF

Editor's Choice

Association of UGT1A1 Genetic Variants with Increases in Bilirubin Levels

Editorial Staff

05-07
- PDF
Selective Serotonin Reuptake Inhibitors Response and the Impact of CYP2C19 Metabolizer Status

Editorial Staff

05-07
- PDF
Blood Direct PCR for Detection of CYP2C19 and CYP4F2 Variants

Editorial Staff

05-07
- PDF
Plasma Level Determination and Pharmacogenetics of Clozapine

Editorial Staff

05-07
- PDF
Treprostinil Dose in Pulmonary Arterial Hypertension and the Role of Two Polymorphic Genetic Loci

Editorial Staff

05-07
- PDF

Research Articles

Cytochrome CYP2B6 Gene Polymorphism and Urinary Adverse Effects in Pakistani Breast Cancer Patients taking Cyclophosphamide

Muhammad Ijaz, Zunaira Shahzad, Taseer Ahmad

09-18
Association Between Cytochrome P450 2C9 Gene Polymorphisms and Blood Pressure in Response to Losartan

Attia Qayyum, Waseem Ashraf, Sana Javaid, Imran Imran, Iram Kaukab

19-26
- PDF

Review Articles

Genotype-Related Efficacy and Adverse Effects of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder

Fatima Siraj Memon, Arooj Fatima Sheikh

27-42
- PDF
A Review of the Genetic Variants Affecting Efficacy and Adverse Effects of Standard of Care Treatment in Patients with Chronic Myelogenous Leukemia

Aman Ullah, Fawad Ali, Syed Aun` Muhammad, Syed Shams Ul Hassan

43-58
- PDF
Hepatic Adverse Effects of Anti-Mycobacterium Tuberculosis Drugs and Their Associations with Various Genetic Variants

Sadia Javed, Zainab Akmal

59-78
- PDF